SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership[Amend]
SEC Accession No. 0001193125-15-385412
Filing Date
2015-11-23
Accepted
2015-11-23 17:13:06
Documents
3
Filing Date Changed
2015-11-23
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d68063dsc13da.htm SC 13D/A 71713
2 EX-99.5 d68063dex995.htm EX-99.5 43116
3 EX-99.6 d68063dex996.htm EX-99.6 71633
  Complete submission text file 0001193125-15-385412.txt   188288
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45947 | Film No.: 151250429
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A